Introduction
Fragile X syndrome (FXS) is one of the most common heritable causes of intellectual disability (ID) with an estimated prevalence between 1 in 4000–7000 for the male population, and 1 in 8000–11,000 for the female population (Hunter et al.
2014). FXS is caused by a full mutation in the FMR1 gene on the X chromosome, caused by unstable expansion of the cytosine–guanine–guanine (CGG) repeat at the 5′untranslated region. A repeat extending beyond 200 repeats inhibits FMR1 transcription, resulting in loss or heavy reduction of the protein product FMRP, and hence the FXS phenotype (Pieretti et al.
1991).
Clinical features of male patients include developmental delay and dysmorphic features such as an elongated face, prominent forehead, large ears, and macro-orchidism (Ciaccio et al.
2017). The intelligence quotient (IQ) of males varies with a mean of 40–50 (Alanay et al.
2007; Merenstein et al.
1996). The behavioral phenotype in males can include attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), anxiety, aggressive behavior and self-injurious behavior (Ciaccio et al.
2017). Manifestations in adult males are understudied (Schneider et al.
2013), and include seizures, movement disorders, gastrointestinal problems, hypertension, obesity and heart problems (Utari et al.
2010). Relatively low cholesterol levels have also been reported (Berry-Kravis et al.
2015). The behavioral phenotype seems to persist, although hyperactivity declines. Also, cognitive and adaptive functioning have been reported to decline (Fisch et al.
2002; Klaiman et al.
2014).
Females with FXS generally have milder symptoms due to presence of one normally FMRP-producing X chromosome, and studies on manifestations in both childhood and adulthood are limited. Approximately 53–71% of females with full mutations have IQs in the borderline or intellectual disability range (de Vries et al.
1996; Hagerman et al.
1992). Females with the full mutation are more likely to present with social anxiety, shyness, social avoidance, withdrawal, language deficits, mood lability, and depression (Bennetto et al.
2001; Hagerman et al.
1992). In adult females, most frequent manifestations include gastrointestinal symptoms, hypertension and obesity. Neurological problems can occur, but less frequently compared with males with FXS (Utari et al.
2010). Specific research on mental health in adult female patients is lacking, although clinical experience indicates that the behavioral phenotype persists in adult life.
An American healthcare guideline is available for pediatric and adolescent patients with FXS (Hersh et al.
2011). The American Academy of Pediatrics advises periodic health assessments throughout childhood and adolescence, including a full developmental and educational assessment, an evaluation of the cognitive level and a medical screening for medical issues associated with FXS. In this guideline, the adult population is only mentioned briefly. No specific guideline is available for the transitional period or for adult patients with FXS.
The transitional age is usually defined as the life span between 15 and 25 years, and is a stage of physical and psychological development in which many transitions take place, involving daytime occupation, living arrangements and relationships. Transitional healthcare is defined as “the purposeful, planned movement of adolescents and young adults with chronic physical and medical conditions from child-centred to adult-oriented healthcare systems” (Blum et al.
1993), and takes place during the same period. This healthcare transition is often problematic, as specialized multidisciplinary healthcare for adults with rare genetic disorders is often unavailable (Van Lierde et al.
2013). Loss to follow-up often occurs, leading to poor health outcomes (Goossens et al.
2016). Literature on transitional health care for patients with FXS are limited, even though difficulties in access to a qualified primary care provider and specialty services have been reported (Wheeler et al.
2018). Also, some factors associated with loss to follow-up have been identified (Kidd et al.
2017). In patients with ASD (Friedman et al.
2013), epilepsy (Borlot et al.
2014; Geerlings et al.
2015), and ID (Young-Southward et al.
2017b), comorbidity all present in FXS, an unsuccessful transition leads to poor outcomes on multiple domains. Areas of concern in young adults with ID are physical and mental health and well-being, with obesity, sexual health, social relationships, employment and independent living being areas of concern (Young-Southward et al.
2017a; Luftig and Muthert
2005). Studies reporting on the experience of parents of children with ID of their child’s transitional age phase showed that most parents were not satisfied with information provision, coordination of care, access to adult health care providers, and knowledge of the health care provider (Griffith et al.
2011; Udwin et al.
1998).
Up to now, little is known about the worries and the healthcare needs of young adult male and female FXS patients and their parents, and no guidelines for adults with FXS are available, even though patients remain affected in adulthood (Hartley et al.
2011; Smith et al.
2012). Thorough assessment of the care needs driven by patient information will assist in the development of care guidelines for adults, including transitional care, and in providing optimal and holistic care for this vulnerable patient group. Hence, we performed a qualitative study to assess the full spectrum of the worries and the perceived healthcare needs in young adults with FXS, also including parents as representatives. Physical, psychological and socio-economical domains were discussed, and worries and needs were categorized according to the International Classification of Functioning and Disability (ICF) (WHO
2001) to provide a comprehensive interpretation. These patient-driven data were used to formulate recommendations for transitional and adult care, with the aim to improve care for adult patients with FXS.
Discussion
The patient-driven, qualitative data yielded in the current study revealed a myriad of needs on physical and mental health domains, activities and participation, and environmental domains for young adult males and females with FXS. Our study shows that the burden of FXS is not limited to physical and mental health issues and differs for men and women, enabling us to formulate recommendations regarding the organization and the content of care.
Mental Health
For males with FXS, the prevailing theme of anxiety concurs with reports in the literature: 70–86.2% of males with FXS meet criteria for an anxiety disorder (Bailey et al.
2008; Cordeiro et al.
2011; Wheeler et al.
2014). Parents reported worsening of aggression and self-injurious behavior during episodes of high anxiety and/or arousal. This confirms observations that sensory issues and hyperactivity were significant predictors of the frequency of aggression, while sensory issues and anxiety were predictive of the severity of aggression (Wheeler et al.
2016). The symptoms of autism that remained a concern of parents of male patients, confirms that autistic features persist over time in FXS (Smith et al.
2012) and necessitates appropriate care also in adulthood. Males with FXS and ASD tend to have lower IQ scores, poorer adaptive skills, and less advanced language skills than individuals with FXS without ASD (Bailey et al.
1998; Philofsky et al.
2004), perhaps also contributing to the concerns of parents.
In females with FXS, as reported by patients as well as parents, anxiety disorders were also a common concern, confirming observations that 76.9% of females (ages 5.0–33.3 years) met criteria for an anxiety disorder, with many more showing subclinical symptoms of anxiety (Cordeiro et al.
2011). The discussed limitations in attention, planning and organizing confirm the reported impairments in executive functioning in this group (Bennetto et al.
2001). ASD and limited social skills were also mentioned. Although 16–20% of females with FXS meet diagnostic criteria for autism (Hall et al.
2008; Kaufmann et al.
2017), social skill impairments in females with FXS could also be related to (a combination of) underlying (social) anxiety, attentional deficits, low self-esteem, and/or executive dysfunction, and should be further investigated.
The tendency to experience and communicate psychological distress in the form of physical symptoms, henceforth called somatization, was discussed as a concern by parents for males as well as females with FXS, and has not been previously described in FXS. Although there is very limited evidence on psychological defense mechanisms in general, or on somatization in intellectual disability, it seems reasonable to assume that cognitive impairments, anxiety, and limited coping and defense mechanisms may account for the seemingly frequent occurrence of somatoform complaints in these patients. Diagnosing somatization must be performed prudently after thorough physical evaluation and professionals must remain aware of abnormal pain presentation and atypical presentation of physical complaints in patients with FXS and ID in general.
Sexuality, Romantic Relationships, Family Planning
Parents of male patients discussed public masturbation, other inappropriate self-stimulatory behavior, and atypical sexual interests. Parents had many questions on sexual development but could not find expertise on this domain. Although the American National Fragile X Foundation has published an overview for parents on how to approach sexuality issues in FXS (Bergner et al.
2012), such an overview is not yet available in the Netherlands.
Initiating and maintaining social relationships was difficult for female patients as well as for the males. In general, parents of male patients agreed this was not experienced as a problem by their sons. Female patients, however, suffered of their limitations in social and romantic relationships, causing social anxiety and loneliness. Hartley et al. (
2011) found that only 60% of adult females had considerable friendships and only one-third of the women with FXS lived independently, often with a spouse or romantic partner (Hartley et al.
2011), suggesting that support in initiating and maintaining social and romantic relationships is needed for these vulnerable women.
Physical Health
Although literature and guidelines focus mostly on somatic issues in children (Hersh et al.
2011), these issues persist and may worsen in adulthood.
Abnormal pain presentation was a big concern for parents of males. This abnormal pain perception however, could be better perceived as an abnormal pain presentation response (Foley and McCutcheon
2004), and De Knegt et al. even hypothesize that patients with FXS may suffer from an increase in pain perception (de Knegt and Scherder
2011). Noticing behavioral changes consistent with having pain is often difficult, as these changes may be subtle or different from an expected response (Foley and McCutcheon
2004), and the international guideline of the National Institute for Health and Care Excellence (NICE) (NICE
2015) emphasizes the need to rule out health problems as a cause of challenging behavior.
Physical health problems such as ear infections, epilepsy, and motor problems were noted as concerns in both patient groups. Other known physical health features of male patients with FXS, such as mitral valve anomalies, joint hypermobility or refractive eye problems were not mentioned by parents, which can be explained by the low frequency and disease burden of these features in adults (Ciaccio et al.
2017). Lack of awareness might also play a role. Features such as neurological symptoms (seizures and movement disorders), gastrointestinal symptoms, hypertension and obesity are frequent in adults with FXS (Utari et al.
2010) but were not mentioned as a concern. Recommendations for monitoring physical health, including motivational support for lifestyle-related issues such as achieving and maintaining a healthy body weight, refraining from excessive alcohol consumption, smoking cessation, searching opportunities for physical activities are summarized in Table
5.
Table 5
Clinical recommendations for transitional and adult care, based on literature and findings of our study
ICF domain | Screen males for: | Screen females for: | Provide |
Impairment of body functions and structures |
Physical health
• Neurological problems • Gastrointestinal problems • Obesity • Hypertension • Heart-problems • Use of medication and side effects • Abnormal pain perception and presentation • Fatigue • Contraception |
Physical health
• Gastrointestinal problems • Obesity • Hypertension • Use of medication and side effects • Fatigue • Questions on menstruation regulation, contraception, family planning | Yearly screening by easily accessible FXS-expert, screening on all domains, with organ-specific care when indicated Motivational support e.g. for life-style related issues Close communication between GP, care professionals and FXS-experts |
Mental health
• Anxiety • Symptoms of ASD • Symptoms of ADHD • Depressive symptoms • Cognitive and/or adaptive functioning • Somatization |
Mental health
• Anxiety • Symptoms of ASD • Symptoms of ADHD • Depressive symptoms • Somatization • Cognitive functioning • Executive functioning impairments | Yearly screening for mental health issues Episodic (neuro)psychological evaluation and psycho-education, e.g. at least once per 5 years When indicated: interventions with (non-verbal) behavioral therapies and psychotropic medication Peer groups |
Activity limitations and participation restriction |
Participation and work
• Self-management • Participation • Adequate work or daytime occupation • Friendships • Recreation, exercise
Relationships and sexuality
• (Romantic) relationships • Sexual development and education • Inappropriate sexual behavior |
Participation and work
• Self-management • Participation • Adequate work or daytime occupation • Friendships • Recreation, exercise • Social vulnerability
Relationships and sexuality
• (Romantic) relationships • Sexual development and education • Family planning | Involvement of a social worker to optimize socialization and independence Information and advice for employers and social services Involvement of a job coach for appropriate daytime occupation Discuss issues separately with patients as well as parents/caregivers |
Environmental factors | Administrative burden Financial problems Living circumstances Information and knowledge on FXS, also for environment Parental stress Transitional care | Administrative burden Financial problems Living circumstances Information and knowledge on FXS, also in environment Parental stress Transitional care | Involvement of a social worker and/or coach Information on patient organizations Information material Address parental concerns and increase support in daily life through GP, parent support groups, social services or psychologist Involve both parents and young adults in transition process Designated coordinator of the transition process Plan the transitional process timely, preferably at the beginning of adolescence, in collaboration with a FXS expertise center A FXS expertise center should be easily accessible for the patients, as well as for local healthcare providers Patient organizations could facilitate knowledge on care infrastructure, and help provide information to patients, caregivers, employers, and others |
Use of Medication
For males, many concerns arose about the use of medication. Parents discussed that psychopharmacological drug treatments were not evidence-based, and were generally based on a trial and error system. Indeed, data from Bailey et al. showed that approximately 10%–20% of parents thought that use of psychopharmacological treatment was not helpful for the behavioral problems of their son or daughter with FXS, whereas approximately less than one-third felt the medication was helping significantly (Bailey et al.
2012). Although in recent years progress has been made towards finding more targeted treatment options (Berry-Kravis et al.
2017; Zeidler et al.
2017), there is insufficient evidence-based medicine for FXS. In addition to identifying disease-modifying drugs, randomized controlled trials should be performed for generally prescribed psychotropics such as antipsychotics, anti-depressants, and stimulants to improve management and guidelines for FXS. In the meantime, treatments should be properly indicated, explained, and documented, applying thorough evaluation methods.
Activities and Participation
During adolescence, individuals try to achieve emotional, personal, and financial independence from their parents. However, male patients and most female patients still relied on help from their parents for all of these domains during this period. For women with FXS, Hartley et al. showed that higher age and the ability to interact appropriately were predictive of a higher level of independence in several dimensions of adult life (Hartley et al.
2011), implicating that the transitional period can be protracted, and that support to achieve independency should be maintained in adulthood. Information and appropriate support in the work and living environment could alleviate the stress caused by limited independency. Additionally, peer groups can have a significant positive impact, as has been mentioned by youngsters with Neurofibromatosis Type 1 (Rietman et al.
2018). Lastly, inclusion in appropriate physical activities will improve participation as well as physical and mental health.
Environmental Factors
Parents expressed a lack of knowledge about FXS in most physicians and other healthcare providers, and lack of health evaluations. This is confirmed by a recent study by Visootsak et al., which showed that their patients had not received appropriate FXS-specific care prior to visiting their Fragile X clinic, leading to underdiagnosis and undertreatment (Visootsak et al.
2016). Our study confirms the need for a multidisciplinary team and approach, also for adults with FXS. In the Netherlands, an ID physician would be a key figure in such a team, because of their expertise on ID, genetic neurocognitive disorders and their holistic approach on all ICF domains. Unfortunately, this medical specialty is unavailable elsewhere, and a multidisciplinary team should consist of FXS-specific expertise in internal medicine, psychiatry, psychology, and social work (see Table
5). Additionally, patient organisations are a very important source of information, and such organisations should empower patients to find appropriate information, care and support, including parent and peer support groups.
Parental Stress
Parents of both males and females experienced many concerns and high stress levels, as has also been described in other studies (Hartley et al.
2012; Lewis et al.
2006; McCarthy et al.
2006). Parents worried about the future, about the lack of independence and need for constant guidance of their child. Concerns about their naivety and vulnerability were also frequently reported. Parents also experienced inadequate support in their environment, for instance of family, social networks and employers. Parents of both groups expressed the need for professional support for themselves to cope with their concerns. Care providers as well as patient organizations should provide information on, and support for, parental stress.
Transitional Care
Our study shows different themes for parent- and patient-reported worries, which underline that both parents and young adults should be involved in the transitional process (Lotstein et al.
2009), although care should be taken to optimize autonomy for female patients and mildly affected male patients in particular. In addition, parents are often concerned about the lack of information concerning transition of care, and they expressed the wish for earlier and better coordinated transition planning (Reiss et al.
2005).
Only a few patients in this study experienced a formal transition from pediatric to adult care. Patients with FXS, similar to other neurodevelopmental disorders, are likely to experience problems during transition to adult health care. Reported risk factors may also apply to many patients with FXS, such as living independently from parents, male gender, lower family income, greater travel distance to adult specialized clinic (Goossens et al.
2016), epilepsy (Geerlings et al.
2015), ASD (Friedman et al.
2013), and a lack of knowledge and expertise of healthcare providers on pediatric neurological and neuropsychiatric diseases (Camfield and Camfield
2011).
Although attention for the transition of care from pediatric to adult health services has increased, a recent review of the Cochrane Library showed limited evidence on the efficacy of interventions to improve the transition from pediatric to adult health services (Campbell et al.
2016). However, the need for evidence-based transitional care and interventions is urgent and is emphasized in our study. Also, more attention to the holistic process of moving to adulthood and independence, instead of solely focusing on transfer of medical care, is indispensable (Kirk
2008).
Implications and Recommendations
Our results underline the burden of FXS for both male and female patients, and the need for periodic multidisciplinary care, screening for problems on all ICF domains. As the transitional age and young adulthood is a complex phase in life, we advise yearly screening. As the physical and neuropsychiatric phenotype persists, and cognitive ageing in FXS has been reported at a relatively early age (Schneider et al.
2013), this yearly screening should be continued throughout the lifetime of adults with FXS, including neuropsychological evaluation at least once every 5 years. The need for gender specific care is emphasized by this study, as male and female patients address different worries and needs, although on similar domains. Suggestions for clinical practice in both patient groups are summarized in Table
5.
Strengths and Limitations
An important strength of the present study is the use of both patient- and parent-driven data, in focus groups and individual, semi-structured interviews. The use of focus groups as a method to discuss the worries and needs of the parents and patients has some limitations, such as possible limitations in sharing sensitive issues. However, because we also used individual interviews and reached data saturation, most issues appeared to be addressed.
Most patients and parents were members of the Dutch Foundation for FXS patients, which may have resulted into a biased sample where parents were relatively well-informed and assertive. Purposive sampling of female patients may have resulted in a relatively severe phenotype of these participants. Premutation carrier status of parents was not known; as FXS premutations are associated with anxiety (Bourgeois et al.
2011; Roberts et al.
2009), this may have influenced the data.
Because of the low mean IQ and comorbid ASD and/or anxiety in men with FXS, it was difficult to include male patients who could communicate their concerns and care needs, and more patient-driven information using novel interview methods is needed to improve our understanding of concerns and needs. Recruitment of female patients for this study was difficult, as not many are involved with the Dutch Foundation for FXS patients, and perhaps also due to personality traits such as shyness and anxiety. This recruitment problem is exemplary for the care gap in the female patient population, and our findings underscore the burden of FXS in women and the importance of diagnosis and appropriate care. For both male and female patients, recruitment for interviews was limited. For this reason, caregivers were included as representatives of these patients. The difficulties in recruitment underline the need for national and international collaboration for shared data collection and research activities.
AD(H)D is a common diagnosis in male and female patients with FXS (Sullivan et al.
2006). In our study, this subject was not mentioned by patients or parents. This could be due to decreasing ADHD-symptoms in adults or due to underdiagnosis, as limitations in executive functions were frequently mentioned which often co-occur with ADHD. Another explanation is that in patients with ASD, an additional diagnosis of ADHD was not allowed by the previous Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). In the DSM, fifth edition (DSM-V) this is no longer an exclusion criterion. This emphasizes the need for further research into the adult neuropsychological phenotype, as well as the developmental trajectories and aging process for adolescents and young adults with FXS.
Finally, as the Netherlands is a relatively small and a high-income country in Western Europe, generalization of current findings is limited to similar countries with respect to care infrastructure, expertise and finances. We expect an even larger care gap in lower income countries. However, the U.S. and Canada already have some well-functioning multidisciplinary centers for adults with FXS, which could function as a model for the Netherlands and others.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.